Industry Outlook
The amniocentesis needles market is set to reach from US$ 156.4 Mn in 2018 to US$ 205.8 Mn by 2027 at a compound annual growth rate (CAGR) of 3.1% during the forecast period from 2019 to 2027. Amniocentesis is frequently performed in prenatal diagnosis to identify any chromosomal abnormalities, neural tube defect and fetal infections during pregnancy. Rising public health awareness and implementation of effective health guidelines pertaining to obstetrics and gynecology drive the amniocentesis needles market growth.
Market Synopsis
Get a sample copy for more information
"Optimal length and availability in different gauge increases the popularity of 100 to 150 mm amniocentesis needles among healthcare professionals"
100 to 150 mm needles are spearheading the type segment for amniocentesis needles market. The ergonomic features associated with it such as optimal length and availability in different gauge increase its popularity among healthcare professionals for collection of amniotic fluid. Larger than 150 mm needles are gaining huge traction as it enhances safety and ensures less needle punctures during transabdominal amniocentesis fluid collection in obese pregnant women with increased transabdominal thickness.
Get a sample copy for more information
"Rising public health awareness and affordable healthcare services drive the hospital segment market growth"
Hospitals are dominating the end user segment for amniocentesis needles market. The chief contributing factors influencing its market growth are rising public health awareness regarding prenatal diseases and its effective diagnosis and availability of affordable healthcare services pertaining to obstetrics and gynecology. Diagnostic centers will be projecting impressive growth during the forecast period owing to availability of skilled workforce and advanced equipment utilized in prenatal diagnosis.
"Rising popularity of prenatal diagnosis and existence of major players together drive the market growth in North America"
In 2018, North America held market share of 34.7% and is leading the regional segment for amniocentesis needles market. The important criterions responsible for its dominating market growth are rising popularity of prenatal diagnosis in pregnant women and domicile of market leaders in the region such as CooperSurgical, Inc., Smiths Group, Plc. Medline Industries, Inc. Becton Dickinson & Company etc. Europe held a market share of 31.5% primarily due to effective implementation of health guidelines pertaining obstetrics and gynecology. Supportive regulatory environment provided by the European Medical Agency for the manufacture and sale of amniocentesis needles. Asia Pacific represents 25.2% market share owing to rise in disposable income, developing healthcare infrastructure and highly competitive environment for major players due to emerging local manufacturers of amniocentesis needles.
Get a sample copy for more information
Historical & Forecast Period
This research report presents the analysis of each segment from 2017 to 2027 considering 2018 as the base year for the research. Compounded annual growth rate (CAGR) for each respective segments are calculated for the forecast period from 2019 to 2027.
Report Scope by Segments
The market segmentation comprises of by type, end user and geography.
| ATTRIBUTE |
DETAILS |
| Research Period |
2017-2027 |
| Base Year |
2018 |
| Forecast Period |
2019-2027 |
| Historical Year |
2017 |
| Unit |
USD Million |
| Segmentation |
By Type (2017–2027; US$ Mn)
• Smaller than 100 mm
• 100 mm to 150 mm
• Larger than 150 mm
|
|
By End User (2017–2027; US$ Mn)
• Hospitals
• Diagnostic Centers
• Clinical Research Institutes
|
|
Geography Segment (2017–2027; US$ Mn)
• North America (U.S., Canada)
• Europe (U.K., Germany, Rest of Europe)
• Asia Pacific (China, Japan, Rest of Asia Pacific)
• Latin America (Brazil, Mexico, Rest of Latin America)
• Middle East and Africa (GCC, Rest of MEA)
|
Medical device companies manufacturing amniocentesis needles are Becton Dickinson & Company, Biopsybell Srl, Cook Medical Incorporated, CooperSurgical, Inc., Laboratoire Ccd., Tsunami Medical S.r.l., Medline Industries, Inc., Ri.mos. S.r.l., Smiths Group, Plc. and Rocket Medical, Plc.
Key questions answered in this report
- Which medical device companies are providing amniocentesis needles for prenatal diagnosis?
- What are the latest merger, acquisitions and strategic collaboration taking place in amniocentesis needles market?
- What is the importance of prenatal diagnosis and how is the amniotic fluid collected for initial screening?
- Why is larger than 150 mm amniocentesis needles becoming popular?
- Which factors will favor the diagnostic centers market growth in the near future?
- What factors are related to market growth in developing regions of Asia Pacific and Latin America?
